Exact Mass: 500.1867

Fluticasone propionate

C25H31F3O5S (500.1844)

Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone propionate binds to the glucocorticoid receptor. Unbound corticosteroids cross the membranes of cells such as mast cells and eosinophils, binding with high affinity to glucocorticoid receptors (GR). The results include alteration of transcription and protein synthesis, a decreased release of leukocytic acid hydrolases, reduction in fibroblast proliferation, prevention of macrophage accumulation at inflamed sites, reduction of collagen deposition, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability and subsequent edema, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. In the management of asthma, the glucocorticoid receptor complexes down-regulates proinflammatory mediators such as interleukin-(IL)-1, 3, and 5, and up-regulates anti-inflammatory mediators such as IκB (inhibits NF-κB). Corticosteroids are the most effective anti-inflammatory therapy for allergic diseases. They are believed to inhibit T helper cell type 2 (TH2 T-cell) activation through increased immunoregulatory T cell (CD4+CD25+) suppression (PMID: 15316506). Fluticasone propionate is marketed under the brand name Flixotide and Flixonase by Allen & Hanburys, and Flovent and Flonase by GlaxoSmithKline. Fluticasone propionate is only found in individuals that have used or taken this drug. Hanburys and Flovent and Flonase by GlaxoSmithKline.; Fluticasone propionate is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. It is marketed with the brand name Flixotide and Flixonase by Allen & Fluticasone is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Artonol C

C30H28O7 (500.1835)

Artonol C is found in breadfruit. Artonol C is a constituent of the bark of Artocarpus communis (breadfruit) Constituent of the bark of Artocarpus communis (breadfruit). Artonol C is found in breadfruit and fruits.

L-Tyrosine, N-(2-(methoxycarbonyl)phenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-

C29H28N2O6 (500.1947)

Rolapitant

C25H26F6N2O2 (500.1898)

Quadrangularin C

C30H28O7 (500.1835)

Seguinoside J

C23H32O12 (500.1894)

Erythrolide P

C24H33ClO9 (500.1813)

Benastatin A

C30H28O7 (500.1835)

Euchretin D

C30H28O7 (500.1835)

N-Demethyl-7-O-demethylcelesticetin

C22H32N2O9S (500.1828)

Euchretin E

C30H28O7 (500.1835)

Singapurensine D

C25H28N2O9 (500.1795)

Artonol C

C30H28O7 (500.1835)

2-((Z)-hepta-5-en-1,3-diynyl)tetrahydrofuran-2-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside|panaxfurayne B

C23H32O12 (500.1894)

solenolide B

C24H33ClO9 (500.1813)

Dendrofalconerol B

C30H28O7 (500.1835)

jaborosalactone 3

C28H33ClO6 (500.1966)

O-Rutinoside-3-(3-Hydroxypropyl)phthalide|Pedirutinoside

C23H32O12 (500.1894)

mersinine A

C25H28N2O9 (500.1795)

dendraol A

C30H28O7 (500.1835)

formicinuoside C

C23H32O12 (500.1894)

Artorigidin C

C30H28O7 (500.1835)

mersirachine

C25H28N2O9 (500.1795)

(1R,2S,4S,5S,6R,7R,9S,10S)-1,2,9,15-tetraacetoxy-4,6-dihydroxy-8-oxodihydro-beta-agarofuran

C23H32O12 (500.1894)

Celephtalide B

C23H32O12 (500.1894)

16-Chloromilolide B

C24H33ClO9 (500.1813)

Fluticasone propionate

C25H31F3O5S (500.1844)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Fluticasone

C25H31F3O5S (500.1844)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents CONFIDENCE standard compound; INTERNAL_ID 2831 D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Cys His Asn Gln

C18H28N8O7S (500.1802)

Cys His Gln Asn

C18H28N8O7S (500.1802)

Cys Asn His Gln

C18H28N8O7S (500.1802)

Cys Asn Gln His

C18H28N8O7S (500.1802)

Cys Gln His Asn

C18H28N8O7S (500.1802)

Cys Gln Asn His

C18H28N8O7S (500.1802)

Asp Glu His Thr

C19H28N6O10 (500.1867)

Asp Glu Thr His

C19H28N6O10 (500.1867)

Asp Phe Gly Tyr

C24H28N4O8 (500.1907)

Asp Phe Tyr Gly

C24H28N4O8 (500.1907)

Asp Gly Phe Tyr

C24H28N4O8 (500.1907)

Asp Gly Tyr Phe

C24H28N4O8 (500.1907)

Asp His Glu Thr

C19H28N6O10 (500.1867)

Asp His Thr Glu

C19H28N6O10 (500.1867)

Asp Thr Glu His

C19H28N6O10 (500.1867)

Asp Thr His Glu

C19H28N6O10 (500.1867)

Asp Tyr Phe Gly

C24H28N4O8 (500.1907)

Asp Tyr Gly Phe

C24H28N4O8 (500.1907)

Glu Asp His Thr

C19H28N6O10 (500.1867)

Glu Asp Thr His

C19H28N6O10 (500.1867)

Glu Glu His Ser

C19H28N6O10 (500.1867)

Glu Glu Ser His

C19H28N6O10 (500.1867)

Glu His Asp Thr

C19H28N6O10 (500.1867)

Glu His Glu Ser

C19H28N6O10 (500.1867)

Glu His Ser Glu

C19H28N6O10 (500.1867)

Glu His Thr Asp

C19H28N6O10 (500.1867)

Glu Ser Glu His

C19H28N6O10 (500.1867)

Glu Ser His Glu

C19H28N6O10 (500.1867)

Glu Thr Asp His

C19H28N6O10 (500.1867)

Glu Thr His Asp

C19H28N6O10 (500.1867)

Phe Asp Gly Tyr

C24H28N4O8 (500.1907)

Phe Asp Tyr Gly

C24H28N4O8 (500.1907)

Phe Gly Asp Tyr

C24H28N4O8 (500.1907)

Phe Gly Tyr Asp

C24H28N4O8 (500.1907)

Phe Tyr Asp Gly

C24H28N4O8 (500.1907)

Phe Tyr Gly Asp

C24H28N4O8 (500.1907)

Gly Asp Phe Tyr

C24H28N4O8 (500.1907)

Gly Asp Tyr Phe

C24H28N4O8 (500.1907)

Gly Phe Asp Tyr

C24H28N4O8 (500.1907)

Gly Phe Tyr Asp

C24H28N4O8 (500.1907)

Gly Tyr Asp Phe

C24H28N4O8 (500.1907)

Gly Tyr Phe Asp

C24H28N4O8 (500.1907)

His Cys Asn Gln

C18H28N8O7S (500.1802)

His Cys Gln Asn

C18H28N8O7S (500.1802)

His Asp Glu Thr

C19H28N6O10 (500.1867)

His Asp Thr Glu

C19H28N6O10 (500.1867)

His Glu Asp Thr

C19H28N6O10 (500.1867)

His Glu Glu Ser

C19H28N6O10 (500.1867)

His Glu Ser Glu

C19H28N6O10 (500.1867)

His Glu Thr Asp

C19H28N6O10 (500.1867)

His Asn Cys Gln

C18H28N8O7S (500.1802)

His Asn Gln Cys

C18H28N8O7S (500.1802)

His Gln Cys Asn

C18H28N8O7S (500.1802)

His Gln Asn Cys

C18H28N8O7S (500.1802)

His Ser Glu Glu

C19H28N6O10 (500.1867)

His Thr Asp Glu

C19H28N6O10 (500.1867)

His Thr Glu Asp

C19H28N6O10 (500.1867)

γ-Hydroxyphenylbutazone glucuronide

C25H28N2O9 (500.1795)

p-Hydroxyphenylbutazone glucuronide

C25H28N2O9 (500.1795)

Met Ser Thr Tyr

C21H32N4O8S (500.1941)

Met Ser Tyr Thr

C21H32N4O8S (500.1941)

Met Thr Ser Tyr

C21H32N4O8S (500.1941)

Met Thr Tyr Ser

C21H32N4O8S (500.1941)

Met Tyr Ser Thr

C21H32N4O8S (500.1941)

Met Tyr Thr Ser

C21H32N4O8S (500.1941)

Asn Cys His Gln

C18H28N8O7S (500.1802)

Asn Cys Gln His

C18H28N8O7S (500.1802)

Asn His Cys Gln

C18H28N8O7S (500.1802)

Asn His Gln Cys

C18H28N8O7S (500.1802)

Asn Gln Cys His

C18H28N8O7S (500.1802)

Asn Gln His Cys

C18H28N8O7S (500.1802)

Gln Cys His Asn

C18H28N8O7S (500.1802)

Gln Cys Asn His

C18H28N8O7S (500.1802)

Gln His Cys Asn

C18H28N8O7S (500.1802)

Gln His Asn Cys

C18H28N8O7S (500.1802)

Gln Asn Cys His

C18H28N8O7S (500.1802)

Gln Asn His Cys

C18H28N8O7S (500.1802)

Ser Glu Glu His

C19H28N6O10 (500.1867)

Ser Glu His Glu

C19H28N6O10 (500.1867)

Ser His Glu Glu

C19H28N6O10 (500.1867)

Ser Met Thr Tyr

C21H32N4O8S (500.1941)

Ser Met Tyr Thr

C21H32N4O8S (500.1941)

Ser Thr Met Tyr

C21H32N4O8S (500.1941)

Ser Thr Tyr Met

C21H32N4O8S (500.1941)

Ser Tyr Met Thr

C21H32N4O8S (500.1941)

Ser Tyr Thr Met

C21H32N4O8S (500.1941)

Thr Asp Glu His

C19H28N6O10 (500.1867)

Thr Asp His Glu

C19H28N6O10 (500.1867)

Thr Glu Asp His

C19H28N6O10 (500.1867)

Thr Glu His Asp

C19H28N6O10 (500.1867)

Thr His Asp Glu

C19H28N6O10 (500.1867)

Thr His Glu Asp

C19H28N6O10 (500.1867)

Thr Met Ser Tyr

C21H32N4O8S (500.1941)

Thr Met Tyr Ser

C21H32N4O8S (500.1941)

Thr Ser Met Tyr

C21H32N4O8S (500.1941)

Thr Ser Tyr Met

C21H32N4O8S (500.1941)

Thr Tyr Met Ser

C21H32N4O8S (500.1941)

Thr Tyr Ser Met

C21H32N4O8S (500.1941)

Tyr Asp Phe Gly

C24H28N4O8 (500.1907)

Tyr Asp Gly Phe

C24H28N4O8 (500.1907)

Tyr Phe Asp Gly

C24H28N4O8 (500.1907)

Tyr Phe Gly Asp

C24H28N4O8 (500.1907)

Tyr Gly Asp Phe

C24H28N4O8 (500.1907)

Tyr Gly Phe Asp

C24H28N4O8 (500.1907)

Tyr Met Ser Thr

C21H32N4O8S (500.1941)

Tyr Met Thr Ser

C21H32N4O8S (500.1941)

Tyr Ser Met Thr

C21H32N4O8S (500.1941)

Tyr Ser Thr Met

C21H32N4O8S (500.1941)

Tyr Thr Met Ser

C21H32N4O8S (500.1941)

Tyr Thr Ser Met

C21H32N4O8S (500.1941)

Flutide

C25H31F3O5S (500.1844)

rolapitant

C25H26F6N2O2 (500.1898)

A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Rolapitant (SCH619734) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant does not interact with CYP3A4. Rolapitant shows potent anti-emetic activity in a ferret emesis model[1][2].

Gliflumide

C25H29FN4O4S (500.1893)

Biotin-PEG2-NHS ester

C21H32N4O8S (500.1941)

Managlinat dialanetil

C21H33N4O6PS (500.1858)

C471 - Enzyme Inhibitor

(1S,3S)-3-ethyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

C26H30NO9+ (500.192)

decanoyl-AMP

C20H31N5O8P- (500.191)

6,9-difluoro-11-hydroxy-17-(3-hydroxy-2-oxopropyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioic acid S-(fluoromethyl) ester

C25H31F3O5S (500.1844)

(2S,3S,4S,5R)-6-[7-carbamoyl-5-hydroxy-1-(4-phenylbutan-2-yl)indol-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H28N2O9 (500.1795)

(2S,3S,4S,5R)-6-[7-carbamoyl-6-hydroxy-1-(4-phenylbutan-2-yl)indol-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H28N2O9 (500.1795)

Fluticasone propionate (Flonase, Veramyst)

C25H31F3O5S (500.1844)

13-deoxycarminomycin(1+)

C26H30NO9 (500.192)

An anthracyline cation that is the conjugate acid of 13-deoxycarminomycin, obtained by protonation of the amino group. Major microspecies at pH 7.3

(12r)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one

C30H28O7 (500.1835)

(9r)-8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol

C30H28O7 (500.1835)

11,12,16-trimethyl (1r,12r,13r,16r,23r)-12-hydroxy-6,8-dioxa-11,20-diazahexacyclo[14.6.1.0¹,¹³.0²,¹⁰.0⁵,⁹.0²⁰,²³]tricosa-2(10),3,5(9),17-tetraene-11,12,16-tricarboxylate

C25H28N2O9 (500.1795)

16,18-dimethyl 18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate

C25H28N2O9 (500.1795)

12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate

C24H33ClO9 (500.1813)

[(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[(2s)-3-(octanoyloxy)-2-(propanoyloxy)propoxy]oxan-2-yl]methanesulfonic acid

C20H36O12S (500.1927)

[(1s,2s,4s,5r,6s,7s,9r,12r)-4,5,7-tris(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl acetate

C23H32O12 (500.1894)

12-(acetyloxy)-9-(chloromethyl)-2,3-dihydroxy-4,13,18-trimethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadec-8-en-14-yl acetate

C24H33ClO9 (500.1813)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(r)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

(5r,5ar,6as,6bs,10ar,11r,12as,12bs,12cs)-10a-chloro-5a,11-dihydroxy-3,3',4',6b,12c-pentamethyl-2,6,6a,10,11,12,12a,12b-octahydro-1h-spiro[cyclohexa[j]aceanthrylene-5,2'-furan]-4,5',7-trione

C28H33ClO6 (500.1966)

1-(3,5-dihydroxy-2-{[(4-methoxy-4-oxobutan-2-yl)oxy]carbonyl}phenyl)propan-2-yl 4-hydroxy-3-[(3-hydroxybutanoyl)oxy]butanoate

C23H32O12 (500.1894)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-2-{[(2r)-2-[(5z)-hept-5-en-1,3-diyn-1-yl]oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C23H32O12 (500.1894)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-2-{[(2r)-2-[(5e)-hept-5-en-1,3-diyn-1-yl]oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C23H32O12 (500.1894)

[4,5,7-tris(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl acetate

C23H32O12 (500.1894)

3,11,12-trimethyl (6ar,12r,12ar)-12-hydroxy-10-methoxy-4-[(1e)-3-oxoprop-1-en-1-yl]-1h,2h,5h,6h,12ah-pyrrolo[2,3-n]phenanthridine-3,11,12-tricarboxylate

C25H28N2O9 (500.1795)

(1r,2r,5r,6s,10r,11r,12s,14r,15s,16s,17r)-12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate

C24H33ClO9 (500.1813)

3-[(3s)-3-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}butyl]-3h-2-benzofuran-1-one

C23H32O12 (500.1894)

11,17-dihydroxy-7,7,20,20-tetramethyl-4-(3-methylbut-2-en-1-yl)-2,6,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5(10),8,11,15(24),16,18(23),21-nonaen-13-one

C30H28O7 (500.1835)

(2r)-n-[(1s,2s)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-{[2-(2-hydroxybenzoyloxy)ethyl]sulfanyl}oxan-2-yl]propyl]pyrrolidine-2-carboximidic acid

C22H32N2O9S (500.1828)

(1r,2r,5r,6s,10s,11s,12s,14r,15s,16s,17r)-12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate

C24H33ClO9 (500.1813)

5,13,17,19-tetrahydroxy-22,22-dimethyl-15-oxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4(9),5,7,10,13,16,18,20-decaene-6-carboxylic acid

C30H28O7 (500.1835)

10a-chloro-5a,11-dihydroxy-3,3',4',6b,12c-pentamethyl-2,6,6a,10,11,12,12a,12b-octahydro-1h-spiro[cyclohexa[j]aceanthrylene-5,2'-furan]-4,5',7-trione

C28H33ClO6 (500.1966)

[(3s,4s,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate

C23H32O12 (500.1894)

(5-{[4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl)methyl hex-2-enoate

C23H32O12 (500.1894)

(12s)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one

C30H28O7 (500.1835)

(1s,2r,3r,4r,7s,8e,12r,13s,14s,16s,18r)-12-(acetyloxy)-9-(chloromethyl)-2,3-dihydroxy-4,13,18-trimethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadec-8-en-14-yl acetate

C24H33ClO9 (500.1813)

3,11,12-trimethyl 12-hydroxy-10-methoxy-4-(3-oxoprop-1-en-1-yl)-1h,2h,5h,6h,12ah-pyrrolo[2,3-n]phenanthridine-3,11,12-tricarboxylate

C25H28N2O9 (500.1795)

2-[(2-{[2-(hept-5-en-1,3-diyn-1-yl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C23H32O12 (500.1894)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(s)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol

C30H28O7 (500.1835)

4-{[1-(3,5-dihydroxy-2-{[(4-methoxy-4-oxobutan-2-yl)oxy]carbonyl}phenyl)propan-2-yl]oxy}-4-oxobutan-2-yl 3,4-dihydroxybutanoate

C23H32O12 (500.1894)

2-(3,5-dihydroxyphenyl)-1-[ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

16,18-dimethyl (1s,2r,6r,17s,18r,19r,21s,23s)-18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate

C25H28N2O9 (500.1795)

11,17-dihydroxy-7,7,20,20-tetramethyl-10-(3-methylbut-2-en-1-yl)-2,8,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5,9,11,15(24),16,18(23),21-nonaen-13-one

C30H28O7 (500.1835)

[(3r,4s,5r)-5-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate

C23H32O12 (500.1894)

[(3s,4r,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate

C23H32O12 (500.1894)

n-[2-hydroxy-1-(3,4,5-trihydroxy-6-{[2-(2-hydroxybenzoyloxy)ethyl]sulfanyl}oxan-2-yl)propyl]pyrrolidine-2-carboximidic acid

C22H32N2O9S (500.1828)